Author Archives: admin


The global cell expansion market is projected to reach US$ 42,837.11 Mn in 2027 from US$ 11,929.43 Mn in 2018 – Yahoo Finance

The cell expansion market is expected to grow with a CAGR of 15. 6% from 2019-2027. Driving factors include increasing adoption of regenerative medicines, rising prevalence of cancer. However, the risk contamination during cell expansion is expected to hamper the market during the forecast period.

New York, Feb. 17, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cell Expansion Market to 2027 - Global Analysis and Forecasts By Product ; Cell Type ; Application ; End User, and Geography" - https://www.reportlinker.com/p05862085/?utm_source=GNW

Cancer is one of the major cause of human death worldwide.In recent years, the cases of cancer have been increasing tremendously and the trend is anticipated to remain the same in the upcoming years.

According to the World Health Organization in 2018, approximately 9.6 million deaths across the globe were due to cancer. Furthermore, the National Cancer Institute predicted that in 2018, approximately 1,735,350 new cancer cases would be diagnosed in the US.

Changes in lifestyle have resulted in more exposure to oncogenic factors.Cancer can be cured if diagnosed and treated at an initial stage.

Cancer sequencing using next-generation sequencing (NGS) methods provides more information. Additionally, cell expansion related procedures also aids in research, diagnostics and treatment of cancer.Furthermore, Asia Pacific region is also facing the problem of the growing prevalence of cancer.The top 15 countries with Cancer prevalence are Japan, Taiwan, Singapore, South Korea, Malaysia, Thailand, China, Philippines, Sri Lanka, Vietnam, Indonesia, Mongolia, India, Laos, and Cambodia.

According to the National Institute of Cancer Prevention and Research (NICPR), in 2018, in India, total deaths due to cancer were 784,821.

The global Cell Expansion market is segmented by product, cell type, application, end user.Based on product, the cell expansion market is segmented into consumables and instruments.

In 2018, the consumables accounted for the largest market share in the global cell expansion market by product.These consumables are essential components of any laboratory experiment hence they are expected to witness significant growth during the forecast period.

Based on cell type, the cell expansion market has been segmented into human cell and animal cell.Furthermore based on application the cell expansion market has been segmented into Regenerative Medicine And Stem Cell Research, Cancer And Cell-Based Research and Other Applications.

Based in end user market is segmented into Biopharmaceutical And Biotechnology Companies, Research Institutes, cell banks and others.

Some of the essential primary and secondary sources included in the report are the National Institute of Cancer Prevention and Research (NICPR), Association for Management Education and Development, Center for Cancer Research, International Society for Stem Cell Research (ISSCR), American Association of Blood Banks (AABB), National Institute of Cancer Prevention and Research and others.Read the full report: https://www.reportlinker.com/p05862085/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

Read this article:
The global cell expansion market is projected to reach US$ 42,837.11 Mn in 2027 from US$ 11,929.43 Mn in 2018 - Yahoo Finance

Global Stem Cell Assay Market Strategies and Insight Driven Transformation 2019-2025 – Instant Tech News

TheStem Cell Assay Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 20162024published and promoted byZion Market Researchprovides in-depth segment analysis of the market being effective in several sectors, thereby providing valuable insights to the rivals.The globalStem Cell Assay Marketreport offers the realistic data gathered on the basis of various key factors such as manufacture and services. It also represents various market trends, developments, abilities, and technologies in the global Stem Cell Assay Market. Data collected in the report helps the user to enhance ideas about the global Stem Cell Assay Market.

FREE | Request Sample Report of Stem Cell Assay Market Report @https://www.zionmarketresearch.com/sample/stem-cell-assay-market

Our Free Complimentary Sample Report Accommodate a Brief Introduction of the research report, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology

The report helps the new entrants in the global Stem Cell Assay Market to make planned decisions enhancing their businesses. It presents the deep analysis of the profits and loss statistics, item value, manufacturing abilities, distribution channels, and embracing classifications of the global Stem Cell Assay Market.

The research report focuses on a range of amendments done in the global Stem Cell Assay Market to improve its development implementation. It also demonstrates a comprehensive analysis of the Stem Cell Assay Market. The data highlighted in the global Stem Cell Assay Market report works as a helpful guide for the communicative andcleararrangement. It helps the user to make strategic moves to expand their businesses in the predicted period.

Download Free PDF Report Brochure@https://www.zionmarketresearch.com/requestbrochure/stem-cell-assay-market

This report highlights facts and figures of the Stem Cell Assay Market in earlier years. It also studies the revenue and the volume of the industry. It predicts the future aspects and calculations of the market on the basis of previous situations of global Stem Cell Assay Market.

The global Stem Cell Assay Market report emphasizes the key factors affecting the global Stem Cell Assay Market from every region. These key factors include market growth, market projections, restrains, projections, and drivers of the global Stem Cell Assay Market. Demand ratio and progression of ground-breaking data are some of the key elements that make the global Stem Cell Assay Market report a rich source of guidance.

In conclusion, the global Stem Cell Assay Market research report provides the user with ideal industry options and Stem Cell Assay Market-related trending activities. It provides the detailed analysis of the dominating market players in the global market. It also covers the market shares of the key market player along with their products, pictures, market share, figures, and graphs.

Major Market Players Included in This Report:

Thermo Fisher Scientific Inc., GE Healthcare, Cell Biolabs, Promega CorporationInc., Hemogenix Inc., Merck KGaA, and STEMCELL Technologies Inc. The other key players in the global market include Bio-Rad LaboratoriesInc., Cellular Dynamics InternationalInc

Promising Regions & Countries Mentioned In The Stem Cell Assay Market Report:

To view TOC of this report is available upon request @https://www.zionmarketresearch.com/toc/stem-cell-assay-market

Available Array of Customizations:

Inquire more about this report @https://www.zionmarketresearch.com/inquiry/stem-cell-assay-market

Essential points covered in Global Stem Cell Assay Market 2020 Research are:-

Reasons for Buying this Report

Thanks for reading this article; you can also get individual chapter wise section or region wise report versions like North America, Europe or Asia

The rest is here:
Global Stem Cell Assay Market Strategies and Insight Driven Transformation 2019-2025 - Instant Tech News

Cell Viability Assays Market to be worth Around USD 5.12 Billion By 2025 – Zion Market Research – MENAFN.COM

(MENAFN - EIN Presswire) Global Cell Viability Assays Market expected to generate around USD 5.12 billion by 2025, at a CAGR of around 8.3% between 2019 and 2025

NEW YORK, NEW YORK, UNITED STATES, February 19, 2020 / EINPresswire.com / -- Zion Market Research has published a new report titled '' Cell Viability Assays Market by Product (Consumables and Instruments), by Application (Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, and Others), and by End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 20182025''. According to the report, the global cell viability assays market was valued at approximately USD 2.93 billion in 2018 and is expected to generate around USD 5.12 billion by 2025, at a CAGR of around 8.3% between 2019 and 2025.

Cell viability assay is an assay technique where the effect of a compound on cell activity is checked. This is generally used during drug development procedures to check whether the developed drug is useful for the treatment of diseases. The growing occurrence of chronic diseases is fueling the research activities to treat these diseases, which is driving the global cell viability assays market. The growing prevalence of chronic and infectious diseases is fueling the growth of the global cell viability assays market. The growing investments made by the government for drug development, increasing the cell-based research activities, and the development of technologically advanced products for cell-based assays. However, the high cost of the cell viability assay instruments may hinder the cell viability assays market in the future.

Get Free Research Report Sample PDF for more Insights - https://www.zionmarketresearch.com/sample/cell-viability-assays-market/news

The global cell viability assays market is divided into product, application, and end-user. By product, the cell viability assays market is bifurcated into instruments and consumables. The consumables segment includes assay kits, reagents, and microplates. The assay kits segment include resazurin cell viability assay kits, tetrazolium reduction assay kits, calcein-AM cell viability assay kits, and others. The instruments segment includes cell imaging and analysis systems, automated cell counters, spectrophotometers, and flow cytometers. The consumables segment is anticipated to dominate the cell viability assays market globally in the future, due to the growing demand for assay kits and reagents in research activities related to a cell.

The growing cell-based research is also fueling the growth of the consumables segment in global cell viability assays market. By application, the market is divided into stem cell research, clinical and diagnostic applications, basic research, drug discovery and development, and others. The drug discovery and development segment held the largest share of the global cell viability assays market in 2018, owing to the increasing prevalence of infectious and chronic diseases. By end-user, the market is segmented into hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, academic and research institutes, and others. Pharmaceutical and biotechnological companies dominated the market in 2018, owing to the rising establishments of these companies and increasing research activities conducted by these companies.

By region, North America is predicted to lead the global cell viability assays market in the upcoming years, owing to an increase in the prevalence of infectious diseases, growing research activities, and developed research and clinical laboratories. The Asia Pacific the global cell viability assays market is expected to show the highest growth in the future, owing to the presence of a large patient pool, the high prevalence of chronic and infectious diseases, and increase in research activities related to the development of drugs and pharmaceutical products.

Browse full TOC of this Research Report - https://www.zionmarketresearch.com/toc/cell-viability-assays-market

Some key players of the global cell viability assays market are Bio-Rad Laboratories, Inc., GE Healthcare, PerkinElmer, Danaher Corporation, Promega Corporation, Thermo Fischer Scientific, BioTek Instruments, Biotium, Merck, Becton, Dickinson, and Company, and G-Biosciences, among others.

This report segments the global cell viability assays market as follows:

Global Cell Viability Assays Market: Product Analysis

ConsumablesAssay KitsTetrazolium Reduction Assay KitsResazurin Cell Viability Assay KitsCalcein-AM Cell Viability Assay KitsOthers

ReagentsMicroplatesInstrumentsAutomated Cell CountersSpectrophotometersCell Imaging and Analysis SystemsFlow Cytometers

Global Cell Viability Assays Market: Application Analysis

Basic ResearchStem Cell ResearchDrug Discovery and DevelopmentClinical and Diagnostic ApplicationsOthers

Global Cell Viability Assays Market: End-User Analysis

Academic and Research InstitutesPharmaceutical and Biotechnology CompaniesHospitals and Diagnostic LaboratoriesOthers

Global Cell Viability Assays Market: Regional Analysis

North AmericaThe U.S.EuropeUKFranceGermanyAsia PacificChinaJapanIndiaLatin AmericaBrazilThe Middle East and Africa

Browse Biotechnology Market Research Reports - https://www.zionmarketresearch.com/category/biotechnology

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client''s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to usafter allif you do well, a little of the light shines on us.

Contact Us:

Zion Market Research244 Fifth Avenue, Suite N202New York, 10001, United StatesTel: +49-322 210 92714USA/Canada Toll-Free No.1-855-465-4651Email: Website: https://www.zionmarketresearch.com

Kalpesh DeshmukhZion Market Research+1 855 465 4651email us here Visit us on social media:Facebook Twitter LinkedIn

MENAFN1902202000703196ID1099727175

See the article here:
Cell Viability Assays Market to be worth Around USD 5.12 Billion By 2025 - Zion Market Research - MENAFN.COM

Hematopoietic Stem Cell Transplantation (HSCT) Market Research Report and Overview on Global Market, 2018-2026 – Instant Tech News

According to a report published by TMR market, the Hematopoietic Stem Cell Transplantation (HSCT) economy is expected to witness a CAGR growth of XX% within the forecast period (2019-2029) and reach at a value of ~US$ at the ending of 2029. The macro-economic and micro elements which are predicted to influence the trajectory of this market are studied in the presented market study.

Light on the raw material throws Suppliers, vendors, manufacturers, and market consumers at the markets value chain. Furthermore, the political and economic scenarios of regions and its effect on the Hematopoietic Stem Cell Transplantation (HSCT) market are discussed within the accounts.

Critical Insights enclosed from this report:

Request Sample Report @ https://www.transparencymarketresearch.co/sample/sample.php?flag=B&rep_id=62316

Competitive Outlook

Light onto the throws Business prospects of prominent players operating from the Hematopoietic Stem Cell Transplantation (HSCT) sector. The item pricing plans, marketing stations that were preferred , product portfolio of most players, and promote presence of each and every company is contained in the report. The dominant players covered in the report include Business, Business two, Business 3, and Company 4.

Regional Assessment

The presented market study sheds light on the Marketplace Scenario in various markets. Furthermore, the governmental and regulatory policies to the prospects of the Hematopoietic Stem Cell Transplantation (HSCT) market in each regions effect is analyzed in the report.

Market segments and sub-segments

The regional analysis covers:

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industrys value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

Note:Although care has been taken to maintain the highest levels of accuracy in TMRs reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request For Discount On This Report @ https://www.transparencymarketresearch.co/sample/sample.php?flag=D&rep_id=62316

The report Suits the questions pertaining To the Hematopoietic Stem Cell Transplantation (HSCT) economy:

Reasons TMR Sticks out

RequestTOC For ThisReport @ https://www.transparencymarketresearch.co/sample/sample.php?flag=T&rep_id=62316

Read more from the original source:
Hematopoietic Stem Cell Transplantation (HSCT) Market Research Report and Overview on Global Market, 2018-2026 - Instant Tech News

Stem Cell Assay Market Analysis With Key Players, Applications, Trends and Forecast To 2026 – Instant Tech News

Stem Cell Assay Market Overview:

Verified Market Research adds new research report Stem Cell Assay Market Development Overview 2020, The report includes an in-depth analysis of the toggle switch market, taking into account market dynamics, segmentation, geographic expansion, competitive landscape and some other key issues. The market analysts who prepared the report have thoroughly examined the toggle switch market and provided reliable and accurate data. They understand the needs of the industry and customers, which makes it easier for them to focus on the problems that end users have been looking for. The research report provides an analysis of an assessment of existing and future trends in which players can invest. It also includes an assessment of the players financial perspectives and the nature of the competition.

Global Stem Cell Assay market was valued at USD 536.53million in 2016 and is projected to reach USD 2858.95millionby 2025, growing at a CAGR of 20.43% from 2017 to 2025.

Request a Report Brochure @ https://www.verifiedmarketresearch.com/download-sample/?rid=24266&utm_source=ITN&utm_medium=005

Top 10 Companies in the Stem Cell Assay Market Research Report:

Competitive Landscape

The competitive landscape is a must-have information for the marketplayersto withstand the competition present in theglobal Stem Cell Assay market. This further helps the market participants to develop effective strategies to optimize their market positions. Moreover, the competitive analysis helps them to determine potential advantages as well as barriers within the global Stem Cell Assay market. This way, they can monitor how their competitors are implementing various strategies including pricing, marketing, and distribution.

The report analyses thecurrent trends, growth opportunities, competitive pricing, restraining factors, and boosters that may have an impact on the overall dynamics of the global Stem Cell Assay market. The report analytically studies the microeconomic and macroeconomic factors affecting the global Stem Cell Assay market growth. New and emerging technologies that may influence the global Stem Cell Assay market growth are also being studied in the report.

Global Stem Cell Assay Market: Regional Segmentation

For a deeper understanding, the research report includes geographical segmentation of the global Stem Cell Assay market. It provides an evaluation of the volatility of the political scenarios and amends likely to be made to the regulatory structures. This assessment gives an accurate analysis of the regional-wise growth of the global Stem Cell Assay market.

Regions Covered by the global market for Stem Cell Assay :

Middle East and Africa (GCC countries and Egypt)North America (USA, Mexico and Canada)South America (Brazil, etc.)Europe (Turkey, Germany, Russia, Great Britain, Italy, France etc.)Asia Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia and Australia)

Ask for Discount @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=24266&utm_source=ITN&utm_medium=005

The study objectives are:

Important Questions Answered in this Report:-

Get a Complete Market Report in your Inbox within 24 hours @ https://www.verifiedmarketresearch.com/product/Stem-Cell-Assay-Market/?utm_source=ITN&utm_medium=005

About Us:

Verified market research partners with clients to provide insight into strategic and growth analytics; data that help achieve business goals and targets. Our core values include trust, integrity, and authenticity for our clients.

Analysts with high expertise in data gathering and governance utilize industry techniques to collate and examine data at all stages. Our analysts are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research reports.

Contact Us:

Mr. Edwyne FernandesCall: +1 (650) 781 4080Email: [emailprotected]

TAGS: Stem Cell Assay Market Size, Stem Cell Assay Market Growth, Stem Cell Assay Market Forecast, Stem Cell Assay Market Analysis, Stem Cell Assay Market Trends, Stem Cell Assay Market

Read the rest here:
Stem Cell Assay Market Analysis With Key Players, Applications, Trends and Forecast To 2026 - Instant Tech News

Stem Cell Alopecia Treatment Market 2020 Booming by Size, Revenue, Trend and Top Companies 2026 – Instant Tech News

New Jersey, United States, The report titled, Stem Cell Alopecia Treatment Market Size and Forecast 2026 in Verified Market Research offers its latest report on the global Stem Cell Alopecia Treatment market that includes comprehensive analysis on a range of subjects like competition, segmentation, regional expansion, and market dynamics. The report sheds light on future trends, key opportunities, top regions, leading segments, the competitive landscape, and several other aspects of the Stem Cell Alopecia Treatment market. Get access to crucial market information. Market players can use the report back to peep into the longer term of the worldwide Stem Cell Alopecia Treatment market and convey important changes to their operating style and marketing tactics to realize sustained growth.

Get | Download Sample Copy @https://www.verifiedmarketresearch.com/download-sample/?rid=15102&utm_source=ITN&utm_medium=002

Top 10 Companies in the Global Stem Cell Alopecia Treatment Market Research Report:

Global Stem Cell Alopecia Treatment Market: Competitive Landscape

Competitive landscape of a market explains strategies incorporated by key players of the market. Key developments and shift in management in the recent years by players has been explained through company profiling. This helps readers to understand the trends that will accelerate the growth of market. It also includes investment strategies, marketing strategies, and product development plans adopted by major players of the market. The market forecast will help readers make better investments.

Global Stem Cell Alopecia Treatment Market: Drivers and Restrains

This section of the report discusses various drivers and restrains that have shaped the global market. The detailed study of numerous drivers of the market enable readers to get a clear perspective of the market, which includes market environment, government policies, product innovations, breakthroughs, and market risks.

The research report also points out the myriad opportunities, challenges, and market barriers present in the Global Stem Cell Alopecia Treatment Market. The comprehensive nature of the information will help the reader determine and plan strategies to benefit from. Restrains, challenges, and market barriers also help the reader to understand how the company can prevent itself from facing downfall.

Global Stem Cell Alopecia Treatment Market: Segment Analysis

This section of the report includes segmentation such as application, product type, and end user. These segmentations aid in determining parts of market that will progress more than others. The segmentation analysis provides information about the key elements that are thriving the specific segments better than others. It helps readers to understand strategies to make sound investments. The Global Stem Cell Alopecia Treatment Market is segmented on the basis of product type, applications, and its end users.

Global Stem Cell Alopecia Treatment Market: Regional Analysis

This part of the report includes detailed information of the market in different regions. Each region offers different scope to the market as each region has different government policy and other factors. The regions included in the report are North America, South America, Europe, Asia Pacific, and the Middle East. Information about different region helps the reader to understand global market better.

Ask for Discount @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=15102&utm_source=ITN&utm_medium=002

Table of Content

1 Introduction of Stem Cell Alopecia Treatment Market

1.1 Overview of the Market 1.2 Scope of Report 1.3 Assumptions

2 Executive Summary

3 Research Methodology of Verified Market Research

3.1 Data Mining 3.2 Validation 3.3 Primary Interviews 3.4 List of Data Sources

4 Stem Cell Alopecia Treatment Market Outlook

4.1 Overview 4.2 Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Porters Five Force Model 4.4 Value Chain Analysis

5 Stem Cell Alopecia Treatment Market, By Deployment Model

5.1 Overview

6 Stem Cell Alopecia Treatment Market, By Solution

6.1 Overview

7 Stem Cell Alopecia Treatment Market, By Vertical

7.1 Overview

8 Stem Cell Alopecia Treatment Market, By Geography

8.1 Overview 8.2 North America 8.2.1 U.S. 8.2.2 Canada 8.2.3 Mexico 8.3 Europe 8.3.1 Germany 8.3.2 U.K. 8.3.3 France 8.3.4 Rest of Europe 8.4 Asia Pacific 8.4.1 China 8.4.2 Japan 8.4.3 India 8.4.4 Rest of Asia Pacific 8.5 Rest of the World 8.5.1 Latin America 8.5.2 Middle East

9 Stem Cell Alopecia Treatment Market Competitive Landscape

9.1 Overview 9.2 Company Market Ranking 9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview 10.1.2 Financial Performance 10.1.3 Product Outlook 10.1.4 Key Developments

11 Appendix

11.1 Related Research

Request Customization of Report Complete Report is Available @ https://www.verifiedmarketresearch.com/product/stem-cell-alopecia-treatment-market/?utm_source=ITN&utm_medium=002

Highlights of Report

About Us:

Verified market research partners with clients to provide insight into strategic and growth analytics; data that help achieve business goals and targets. Our core values include trust, integrity, and authenticity for our clients.

Analysts with high expertise in data gathering and governance utilize industry techniques to collate and examine data at all stages. Our analysts are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research reports.

Contact Us:

Mr. Edwyne Fernandes Call: +1 (650) 781 4080 Email: [emailprotected]

TAGS: Stem Cell Alopecia Treatment Market Size, Stem Cell Alopecia Treatment Market Growth, Stem Cell Alopecia Treatment Market Forecast, Stem Cell Alopecia Treatment Market Analysis, Stem Cell Alopecia Treatment Market Trends, Stem Cell Alopecia Treatment Market

Read the original here:
Stem Cell Alopecia Treatment Market 2020 Booming by Size, Revenue, Trend and Top Companies 2026 - Instant Tech News

MicroCures Announces Material Transfer Agreement with Henry M. Jackson Foundation for the Advancement of Military Medicine to Support Preclinical…

NEW YORK, Feb. 19, 2020 (GLOBE NEWSWIRE) -- MicroCures, a biopharmaceutical company developing novel therapeutics that harness the bodys innate regenerative mechanisms to accelerate tissue repair, today announced that it has entered into a material transfer agreement (MTA) with the Henry M. Jackson Foundation (HJF) for the Advancement of Military Medicine. Under terms of the agreement, United States Department of Defense researchers will conduct a preclinical study of siFi2, MicroCures lead product candidate, in animal models of spinal cord injury. siFi2, a small interfering RNA (siRNA) therapeutic that can be applied topically, is designed to enhance recovery after trauma.

Researchers, led by Kimberly Byrnes, Ph.D. of Uniformed Services University of the Health Sciences, will evaluate the potential of siFi2 treatment to drive axon regeneration and functional recovery in a rat model of spinal cord injury. As part of this study, multiple siFi2 formulations will be evaluated in order to assist in the identification of a lead formulation to be advanced into clinical development.

MicroCures technology is based on foundational scientific research at Albert Einstein College of Medicine regarding the fundamental role that cell movement plays as a driver of the bodys innate capacity to repair tissue, nerves, and organs. The company has shown that complex and dynamic networks of microtubules within cells crucially control cell migration, and that this cell movement can be reliably modulated to achieve a range of therapeutic benefits. Based on these findings, the company has established a first-of-its-kind proprietary platform to create siRNA-based therapeutics capable of precisely controlling the speed and direction of cell movement by selectively silencing microtubule regulatory proteins (MRPs).

The company has developed a broad pipeline of therapeutic programs with an initial focus in the area of tissue, nerve and organ repair. Unlike regenerative medicine approaches that rely upon engineered materials or systemic growth factor/stem cell therapeutics, MicroCures technology directs and enhances the bodys inherent healing processes through local, temporary modulation of cell motility. siFi2 is a topical siRNA-based treatment designed to silence the activity of Fidgetin-Like 2 (FL2), a fundamental MRP, within an area of wounded tissue or nerve. In doing so, the therapy temporarily triggers accelerated movement of cells essential for repair into an injury area. Importantly, based on its topical administration, siFi2 can be applied early in the treatment process as a supplement to current standard of care.

The U.S. Department of Defense continues to be a valued and trusted partner for MicroCures as we work to advance research of siFi2 with the goal of ultimately delivering transformative treatments to patients with significant unmet medical needs, said David Sharp, Ph.D., co-founder and chief science officer of MicroCures. With a focus in the area of spinal cord injury, this MTA further demonstrates the broad applicability of our technology platform to a range of therapeutic indications. We look forward to collaborating with Dr. Byrnes and her team at Uniformed Services University of the Health Sciences to continue the advancement of this promising program.

Previously conducted research in a rat model of spinal cord injury has demonstrated that treatment with siFi2 allowed axon growth to occur through the inhibitory barriers that typically appear and prevent healing at the site of injury. Conversely, study results failed to demonstrate similar axon growth through these inhibitory barriers for animals administered a siRNA control treatment. Additional preclinical findings have demonstrated functional improvement in rats with spinal cord injury following treatment with siFi2. This was evidenced by significantly improved hind limb locomotor function in siFi2-treated animals as compared to control subjects at Day 5 (p < 0.05) and Day 7 (p < 0.01).

About MicroCures

MicroCures develops biopharmaceuticals that harness innate cellular mechanisms within the body to precisely control the rate and direction of cell migration, offering the potential to deliver powerful therapeutic benefits for a variety of large and underserved medical applications.

MicroCures has developed a broad pipeline of novel therapeutic programs with an initial focus in the area of tissue, nerve and organ repair. The companys lead therapeutic candidate, siFi2, targets excisional wound healing, a multi-billion dollar market inadequately served by current treatments. Additional applications for the companys cell migration accelerator technology include dermal burn repair, corneal burn repair, cavernous nerve repair/regeneration, spinal cord repair/regeneration, and cardiac tissue repair. Cell migration decelerator applications include combatting cancer metastases and fibrosis. The company protects its unique platform and proprietary therapeutic programs with a robust intellectual property portfolio including eight issued or allowed patents, as well as eight pending patent applications.

For more information please visit: http://www.microcures.com

Contact:

Vida Strategic Partners (On behalf of MicroCures)

Stephanie Diaz (investors)415-675-7401sdiaz@vidasp.com

Tim Brons (media)415-675-7402tbrons@vidasp.com

Originally posted here:
MicroCures Announces Material Transfer Agreement with Henry M. Jackson Foundation for the Advancement of Military Medicine to Support Preclinical...

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market by Key Players, Deployment Type, Applications, Vertical, and Region-Global 2026…

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market report is designed by detailed investigation procedure to collect all the necessary data. This report contains the brief profile of leading players in the industry along with their future plans and current developments. Further, report considers the revenue generated from the market analysis and opportunity analysis to estimate the market size. The report initiates with the basic market outlook and structure along with forecast of the various segments and sub-segments.

You Can Get a Sample Copy of this Report at https://www.orianresearch.com/request-sample/1479129

What You Can Expect From Our Report:

Purchase Directly @ https://www.orianresearch.com/checkout/1479129

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market research report involves emphasis on historic along with forecast revenue of the market segments and anticipated growth rates. The chief elements driving and impacting growth market data and analytics are derived from a combination of primary and secondary sources.

The key players covered in this study, Orange County Hair Restoration Center, Hair Sciences Center of Colorado, Anderson Center for Hair, Evolution Hair Loss Institute, Savola Aesthetic Dermatology Center, Virginia Surgical Center, Hair Transplant Institute of Miami, Colorado Surgical Center & Hair Institute

No of Pages: 97

The scope of the Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Report:

Market segment by Type, the product can be split intoPlatelet Rich Plasma InjectionsStem Cell TherapyMarket segment by Application, split intoDermatology ClinicsHospitals

Important Aspects of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Report:

Why To Select This Report:

Complete analysis on market dynamics, market status and competitive Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies view is offered.

Forecast Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Industry trends will present the market drivers, constraints and growth opportunities.

The five-year forecast view shows how the market is expected to grow in coming years.

All vital Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Industry verticals are presented in this study like Product Type, Applications and Geographical Regions.

Table of Contents

1 Study Coverage

2 Executive Summary

3 Breakdown Data by Manufacturers

4 Breakdown Data by Type

4.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Sales by Type

4.2 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue by Type

4.3 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Price by Type

5 Breakdown Data by Application

5.1 Overview

5.2 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Breakdown Data by Application

6 North America

7 Europe

8 Asia Pacific

9 Central & South America

10 Middle East and Africa

11 Company Profiles

12 Future Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

14 Value Chain and Sales Channels Analysis

15 Research Findings and Conclusion

16 Appendix

Customization Service of the Report:-

Orian Research provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities

About Us:Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the worlds most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Read the rest here:
Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market by Key Players, Deployment Type, Applications, Vertical, and Region-Global 2026...

Building a ‘doomsday vault’ to save the kangaroo and koala from extinction – CNET

The road into Batlow is littered with the dead.

In the smoky, gray haze of the morning, it's hard to make out exactly what Matt Roberts' camera is capturing. Roberts, a photojournalist with the Australian Broadcasting Corporation, keeps his lens focused on the road as he rolls into the fire-ravaged town 55 miles west of Canberra, Australia's capital. At the asphalt's edge, blackened livestock carcasses lie motionless.

The grim scene, widely shared on social media, is emblematic of the impact the 2019-20 bushfire season has had on Australia's animal life. Some estimates suggest "many, many billions" of animals have been killed, populations of endemic insects could be crippled and, as ash washes into riverways, marine life will be severely impacted. The scale of the bushfires is so massive, scientists are unlikely to know the impact on wildlife for many years.

But even before bushfires roared across the country, Australia's unique native animals were in a dire fight for survival. Habitat destruction, invasive species, hunting and climate change have conspired against them. Populations of native fauna are plummeting or disappearing altogether, leaving Australia with an unenviable record: It has the highest rate of mammal extinctions in the world.

A large share of Australia's extinctions have involved marsupials -- the class of mammals that includes the nation's iconic kangaroos, wallabies, koalas and wombats. A century ago, the Tasmanian tiger still padded quietly through Australia's forests. The desert rat-kangaroo hopped across the clay pans of the outback, sheltering from the sun in dug-out nests.

Now they're gone.

Australia's 2019-20 bushfire season has been devastating for wildlife.

In a search for answers to the extinction crisis, researchers are turning to one lesser-known species, small enough to fit in the palm of your hand: the fat-tailed dunnart. The carnivorous mouse-like marsupial, no bigger than a golf ball and about as heavy as a toothbrush, has a tiny snout, dark, bulbous eyes and, unsurprisingly, a fat tail. It's Baby Yoda levels of adorable -- and it may be just as influential.

Mapping the dunnart's genome could help this little animal become the marsupial equivalent of the lab mouse -- a model organism scientists use to better understand biological processes, manipulate genes and test new approaches to treating disease. The ambitious project, driven by marsupial geneticist Andrew Pask and his team at the University of Melbourne over the last two years, will see scientists take advantage of incredible feats of genetic engineering, reprogramming cells at will.

It could even aid the creation of a frozen Noah's Ark of samples: a doomsday vault of marsupial cells, suspended in time, to preserve genetic diversity and help prevent further decline, bringing species back from the brink of extinction.

If that sounds far-fetched, it isn't. In fact, it's already happening.

Creating a reliable marsupial model organism is a long-held dream for Australian geneticists, stretching back to research pioneered by famed statistician Ronald Fisher in the mid-20th century. To understand why the model is so important, we need to look at the lab mouse, a staple of science laboratories for centuries.

"A lot of what we know about how genes work, and how genes work with each other, comes from the mouse," says Jenny Graves, a geneticist at La Trobe University in Victoria, Australia, who has worked with marsupials for five decades.

The mouse is an indispensable model organism that shares many genetic similarities with humans. It has been key in understanding basic human biology, testing new medicines and unraveling the mysteries of how our brains work. Mice form such a critical part of the scientific endeavor because they breed quickly, have large litters, and are cheap to house, feed and maintain.

The lab mouse has been indispensable in understanding physiology, biology and genetics.

In the 1970s, scientists developed a method to insert new genes into mice. After a decade of refinement, these genetically modified mice (known as "transgenic mice") provided novel ways to study how genes function. You could add a gene, turning its expression up to 11, or delete a gene entirely, shutting it off. Scientists had a powerful tool to discover which genes performed the critical work in reproduction, development and maturation.

The same capability does not exist for marsupials. "At the moment, we don't have any way of manipulating genes in a devil or a kangaroo or a possum," says Graves. Without this capability, it's difficult to answer more pointed questions about marsupial genes and how they compare with mammal genes, like those of mice and humans.

So far, two marsupial species -- the Tammar wallaby and the American opossum -- have been front and center of research efforts to create a reliable model organism, but they both pose problems. The wallaby breeds slowly, with only one baby every 18 months, and it requires vast swaths of land to maintain.

The short-tailed opossum might prove an even more complicated case. Pask, the marsupial geneticist, says the small South American marsupial is prone to eating its young, and breeding requires researchers to sift through hours of video footage, looking for who impregnated whom. Pask also makes a patriotic jab ("they're American so we don't like them") and says their differences from Australian marsupials make them less useful for the problems Australian species face.

But the dunnart boasts all the features that make the mouse such an attractive organism for study: It is small and easy to house, breeds well in captivity and has large litters.

"Our little guys are just like having a mouse basically, except they have a pouch," Pask says.

Pask (front) and Frankenberg inspect some of their dunnarts at the University of Melbourne.

A stern warning precedes my first meeting with Pask's colony of fat-tailed dunnarts.

"It smells like shit," he says. "They shit everywhere."

I quickly discover he's right. Upon entering the colony's dwellings on the third floor of the University of Melbourne's utilitarian BioSciences building, you're punched in the face by a musty, fecal smell.

Pask, a laid-back researcher whose face is almost permanently fixed with a smile, and one of his colleagues, researcher Stephen Frankenberg, appear unfazed by the odor. They've adapted to it. Inside the small room that houses the colony, storage-box-cages are stacked three shelves high. They're filled with upturned egg cartons and empty buckets, which work as makeshift nests for the critters to hide in.

Andrew Pask

Frankenberg reaches in without hesitation and plucks one from a cage -- nameless but numbered "29" -- and it hides in his enclosed fist before peeking out of the gap between his thumb and forefinger, snout pulsing. As I watch Frankenberg cradle it, the dunnart seems curious, and Pask warns me it's more than agile enough to manufacture a great escape.

In the wild, fat-tailed dunnarts are just as inquisitive and fleet-footed. Their range extends across most of southern and central Australia, and the most recent assessment of their population numbers shows they aren't suffering population declines in the same way many of Australia's bigger marsupial species are.

Move over, Baby Yoda.

As I watch 29 scamper up Frankenberg's arm, the physical similarities between it and a mouse are obvious. Pask explains that the dunnart's DNA is much more closely related to the Tasmanian devil, an endangered cat-sized carnivore native to Australia, than the mouse. But from a research perspective, Pask notes the similarities between mouse and dunnart run deep -- and that's why it's such an important critter.

"The dunnart is going to be our marsupial workhorse like the mouse is for placental mammals," Pask says.

For that to happen, Pask's team has to perfect an incredible feat of genetic engineering: They have to learn how to reprogram its cells.

To do so, they collect skin cells from the dunnart's ear or footpad and drop them in a flask where scientists can introduce new genes into the skin cell. The introduced genes are able to trick the adult cell, convincing it to become a "younger," specialized cell with almost unlimited potential.

The reprogrammed cells are known as "induced pluripotent stem cells," or iPS cells, and since Japanese scientists unraveled how to perform this incredible feat in 2006, they have proven to be indispensable for researchers because they can become any cell in the body.

"You can grow them in culture and put different sorts of differentiation factors on them and see if they can turn into nerve cells, muscle cells, brain cells, blood vessels," Pask explains. That means these special cells could even be programmed to become a sperm or an egg, in turn allowing embryos to be made.

Implanting the embryo in a surrogate mother could create a whole animal.

It took about 15 minutes to get this dunnart to sit still.

Although such a technological leap has been made in mice, it's still a long way from fruition for marsupials. At present, only the Tasmanian devil has had iPS cells created from skin, and no sperm or egg cells were produced.

Pask's team has been able to dupe the dunnart's cells into reverting to stem cells -- and they've even made some slight genetic tweaks in the lab. But that's just the first step.

He believes there are likely to be small differences between species, but if the methodology remains consistent and reproducible in other marsupials, scientists could begin to create iPS cells from Australia's array of unique fauna. They could even sample skin cells from wild marsupials and reprogram those.

Doing so would be indispensable in the creation of a biobank, where the cells would be frozen down to -196 degrees Celsius (-273F) and stored until they're needed. It would act as a safeguard -- a backup copy of genetic material that could, in some distant future, be used to bring species back from the edge of oblivion, helping repopulate them and restoring their genetic diversity.

Underneath San Diego Zoo's Beckman Center for Conservation Research lies the Frozen Zoo, a repository of test tubes containing the genetic material of over 10,000 species. Stacked in towers and chilled inside giant metal vats, the tubes contain the DNA of threatened species from around the world, suspended in time.

It's the largest wildlife biobank in the world.

"Our goal is to opportunistically collect cells ... on multiple individuals of as many species as we can, to provide a vast genetic resource for research and conservation efforts," explains Marlys Houck, curator at the Frozen Zoo.

The Zoo's efforts to save the northern white rhino from extinction have been well publicized. Other research groups have been able to create a northern white rhino embryo in the lab, combining eggs of the last two remaining females with frozen sperm from departed males. Scientists propose implanting those embryos in a surrogate mother of a closely related species, the southern white rhino, to help drag the species back from the edge of oblivion.

For the better part of a decade, conservationists have been focused on this goal, and now their work is paying off: In the "coming months," the lab-created northern white rhino embryo will be implanted in a surrogate.

Sudan, the last male northern white rhinoceros, was euthanized in 2018.

Marisa Korody, a conservation geneticist at the Frozen Zoo, stresses that this type of intervention was really the last hope for the rhino, a species whose population had already diminished to just eight individuals a decade ago.

"We only turn to these methods when more traditional conservation methods have failed," she says.

In Australia, researchers are telling whoever will listen that traditional conservation methods are failing.

"We've been saying for decades and decades, many of our species are on a slippery slope," says John Rodger, a marsupial conservationist at the University of Newcastle, Australia, and CEO of the Fauna Research Alliance, which has long advocated for the banking of genetic material of species in Australia and New Zealand.

In October, 240 of Australia's top scientists delivered a letter to the government detailing the country's woeful record on protecting species, citing the 1,800 plants and animals in danger of extinction, and the "weak" environmental laws which have been ineffective at keeping Australian fauna alive.

Institutions around Australia, such as Taronga Zoo and Monash University, have been biobanking samples since the '90s, reliant on philanthropic donations to stay online, but researchers say this is not enough. For at least a decade, they've been calling for the establishment of a national biobank to support Australia's threatened species.

John Rodger

"Our real problem in Australia ... is underinvestment," Rodger says. "You've got to accept this is not a short-term investment."

The current government installed a threatened-species commissioner in 2017 and committed $255 million ($171 million in US dollars) in funding to improve the prospects of 20 mammal species by 2020. In the most recent progress report, released in 2019, only eight of those 20 were identified as having an "improved trajectory," meaning populations were either increasing faster or declining slower compared to 2015.

A spokesperson for the commissioner outlined the $50 million investment to support immediate work to protect wildlife following the bushfires, speaking to monitoring programs, establishment of "insurance populations" and feral cat traps. No future strategies regarding biobanking were referenced.

Researchers believe we need to act now to preserve iconic Australian species like the koala.

In the wake of the catastrophic bushfire season and the challenges posed by climate change, Australia's extinction crisis is again in the spotlight. Koalas are plastered over social media with charred noses and bandaged skin. On the front page of newspapers, kangaroos bound in front of towering walls of flame.

Houck notes that San Diego's Frozen Zoo currently stores cell lines "from nearly 30 marsupial species, including koala, Tasmanian devil and kangaroo," but that's only one-tenth of the known marsupial species living in Australia today.

"Nobody in the world is seriously working on marsupials but us," Rodger says. "We've got a huge interest in maintaining these guys for tourism, national icons... you name it."

There's a creeping sense of dread in the researchers I talk to that perhaps we've passed a tipping point, not just in Australia, but across the world. "We are losing species at an alarming rate," says Korody from the Frozen Zoo. "Some species are going extinct before we even know they are there."

With such high stakes, Pask and his dunnarts are in a race against time. Perfecting the techniques to genetically engineer the tiny marsupial's cells will help enable the preservation of all marsupial species for generations to come, future-proofing them against natural disasters, disease, land-clearing and threats we may not even be able to predict right now.

Pask reasons "we owe it" to marsupials to develop these tools and, at the very least, biobank their cells if we can't prevent extinction. "We really should be investing in this stuff now," he says. He's optimistic.

In some distant future, years from now, a bundle of frozen stem cells might just bring the koala or the kangaroo back from the brink of extinction.

And for that, we'll have the dunnart to thank.

Originally published Feb. 18, 5 a.m. PT.

Continued here:
Building a 'doomsday vault' to save the kangaroo and koala from extinction - CNET

Lawyer thought her tiredness was down to jet lag until she visited doctor – Mirror Online

A high-flying lawyer who thought she had jet lag after relocating to Hong Kong was actually suffering from an aggressive form of leukaemia.

Alexandra Simpson has spoken out about her cancer battle to encourage others to be mindful of their bodies and to ask their doctors for a blood test if they are worried about any persistent symptoms.

The 26-year-old from Llandudno, north Wales, is now in remission but, to lessen the risk of relapsing she is also having a stem cell transplant, having started a week of chemotherapy before having the procedure on February 21.

Alexandra was 25 when she started suffering from fatigue and blamed her tiredness on her massive career move from London to Hong Kong.

It was only when mysterious bruises popped up all over her body that Alexandra saw a doctor, reports WalesOnline.

Still believing she had the world at her feet, Alexandra relived her horror when she received her blood test results the following day, saying: "The doctor told me, Its not great news, today'."

Alexandra had acute lymphoblastic leukaemia (ALL) cancer of the white blood cells- and her life was under threat so she needed treatment immediately.

The doctor told me hed booked an appointment with a specialist for me at midday, then wished me luck, she said.

I left in floods of tears. It was the middle of the night back home, and I knew I had to tell my mum, but I wanted to give her a few more minutes of not knowing her child had cancer.

I wandered around the city, which was still quite unfamiliar to me, with no idea where to go, she continued.

Eventually, I called home and Mum just kept saying, No.

She saw me as this strong, healthy girl it was shocking that cancer could suddenly hit me so aggressively.

You sometimes imagine how it may feel to be told you have cancer.

"On TV, people always seem to go numb their hearing fades and the room around them swirls. I actually became hyper-aware. I still remember every word the doctor said to me, even now.

And while its been incredibly difficult both for me and the people that have walked alongside me, seeing the horror of it all I wouldnt undo any of what Ive been through.

She added: Before, I think I was a little lost, almost sleepwalking through my twenties.

"But now, Ive learnt to appreciate the little things all those beautiful moments youd otherwise take for granted and have a purpose and a passion in raising awareness of leukaemia.

Doctors now believe that cancerous cells first started to invade Alexandra around January 2019, when she had seen a GP in London because she was feeling rundown and had concernes she was anaemic.

Working in a busy law firm, when she had noticed dark circles around her eyes, she assumed it was her fast-paced lifestyle taking its toll rather than anything more sinister.

She said: I almost got used to having very little energy. I was working long hours and still managing to get myself to the gym three times a week, so I didnt think it was anything overly worrying.

I blamed city life. I kept telling myself Id be moving to Hong Kong soon and would feel better in a new place, with a bit of sunshine.

Alexandras doctor agreed she could be anaemic so suggested she eat more red meat, or try an iron supplement to get her levels up.

Assuming that would be the end of it, Alexandra turned her thoughts to her big move in early March 2019.

When her fatigue did not lift, she said: I kept telling myself Id just moved around the world and that feeling tired was natural but I just wasnt bouncing back from the jetlag.

As I became more comfortable with the new friends I was making out there, they remarked that I still looked pale, despite being in the sweltering heat every day.

Agreeing she could be anaemic, Alexandras doctor suggested she eat more red meat, or try an iron supplement to get her levels up.

]]

So, assuming that would be the end of it, she turned her thoughts to her big move in early March 2019.

When her fatigue did not lift, she said: I kept telling myself Id just moved around the world and that feeling tired was natural but I just wasnt bouncing back from the jetlag.

As I became more comfortable with the new friends I was making out there, they remarked that I still looked pale, despite being in the sweltering heat every day.

It was at the end of March when Alexandra banged her leg getting out of the bath one day and noticed a dramatic bruise forming within minutes that she thought something sinister was happening.

She continued: It kept developing, getting larger and larger, to the point where I was embarrassed to show it, as I could feel people staring, wondering what Id done.

That seemed to almost trigger something in my body and, before long, clusters of bruises sprang up all over, with no explanation as to where theyd come from.

Alexandra looked up her symptoms online and was shocked when almost all of them pointed towards leukaemia.

So, using healthcare benefits she had through work, in April she booked a private appointment to see a doctor, who gave her a blood test with the results back the next morning.

Id just sat down at my desk when my phone started to ring, recalled Alexandra.

I dont think the receptionist even said hello. She just asked, Where are you? and told me to come in right away.

The urgency in her voice was really worrying. When I got there, I was trying to analyse the doctors face. I knew that something serious was going on, as he couldnt quite look at me. Then he told me I had leukaemia.

After wandering around the city and phoning her mum, feeling shaken and disorientated, Alexandra returned to her office and broke the news to her colleagues.

A colleague came over to ask if I was okay, as I was visibly upset. I think she assumed itd be a break-up, or homesickness a more normal problem for a 20-something who had moved across the world to be facing, she said.

When I told her, I watched the colour drain from her face. She sat with me and we talked it all over then, bizarrely, I actually wanted to do a bit of work while I waited for my midday appointment. My colleagues thought I was bonkers, but I needed a distraction.

When Alexandra she saw the specialist later that day she realised how gravely ill she was.

She recalled: He told me I wasnt well enough to fly back to the UK, and I needed to go straight to hospital.

I said, 'Okay, Ill just go home to get some things'. But he told me no, that if I somehow fell or knocked myself on the way, that my blood didnt have enough platelets to form clots, so I could bleed to death.

She continued: "He said, 'You need to go to hospital right now, and just to warn you, youll be there for at least a month'. He was good at keeping me calm, but also making me realise how much danger I was in.

Admitted to hospital, Alexandra was given a bone marrow biopsy, which confirmed her official diagnosis.

According to the charity Leukaemia Care, ALL is a rapidly progressing form of the disease, with almost 350 cases a year diagnosed in UK adults.

Symptoms can include fatigue, fever, frequent infections, unusual bleeding, unexplained weight loss and small purple spots on the skin known as purpura.

Three days after her diagnosis, Alexandra began the first of four gruelling cycles of chemotherapy.

It all happened so quickly, I didnt really have time to consider what I was about to put my body through. I was just focused on getting the cancerous cells eliminated, she said.

"When I look back at that part of everything, it doesnt feel like my life. Its like Im looking at another girl thinking, 'Poor her, shes been through so much'.

As well as the obvious side-effects, like losing my hair and having to deal with everybody staring at me, knowing I was sick, there were all these other little ways it impacted me.

For example, my fitness level plummeted to the point where Id have to take a rest when walking upstairs.

It was like being locked out of my own life. The chemo made me sicker than the cancer, in a way but I knew it was the cure, and I had to keep going.

By May, Alexandra had stabilised enough to fly home, where she continued the rest of her chemotherapy at Manchesters Christie Hospital, finishing in September 2019.

Later that month, she began immunotherapy, where the bodys own immune system is used to fight off cancerous cells.

She said: The form I had targets a specific antigen in the leukemic cells, and uses my own immune system to kill the cancer. The drug I take is slowly infused over a 28-day period, so I carry around a pump that delivers a very small dose every minute.

Now in remission, Alexandra described how her journey has made her re-evaluate life, and find value in small things she may have once taken for granted.

She said: I know now I wasnt prioritising the right things, like chasing that deal at work, or buying the latest designer handbag. Those things do have a place in life, and they are important, but they arent the be all and end all.

Now, things like sitting around the table with my family laughing, or feeling the sun on my neck in the garden those are the moments that mean the most.

For a long time, I put what happened in a box, only to be opened at certain times.

Now Ive gone from being obsessed that nobody would know to look at me what Ive been through, to being proud of my scars.

Ive worked through that denial to find a place of peace. Ive found my cause in life and am so proud to be a part of the cancer community.

Urging people to be mindful of the bodies, she said: You know your body better than anybody, so if you feel something has changed however minor then ask your doctor for a blood test, she said.

The likelihood is it will be something much more minor than leukaemia, but if it is serious, its important to catch it early. Going through this has completely changed my mindset, and Im so glad to still be here to appreciate the little things that make life so beautiful.

View post:
Lawyer thought her tiredness was down to jet lag until she visited doctor - Mirror Online